REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 195 filers reported holding REVANCE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,340,432 | -71.2% | 465,600 | -36.6% | 0.08% | -75.1% |
| Q2 2023 | $18,575,009 | -15.1% | 733,900 | +8.1% | 0.33% | -22.0% |
| Q1 2023 | $21,877,032 | -11.1% | 679,200 | -49.1% | 0.42% | +9.9% |
| Q4 2022 | $24,621,948 | -44.1% | 1,333,800 | -18.2% | 0.38% | -36.8% |
| Q3 2022 | $44,024,000 | – | 1,630,500 | – | 0.61% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NovaQuest Capital Management, L.L.C. | 1,558,426 | $42,779,000 | 61.17% |
| Essex Woodlands Management, Inc. | 3,342,047 | $91,739,000 | 21.30% |
| Sio Capital Management, LLC | 101,292 | $2,780,000 | 1.54% |
| Fosun International Ltd | 472,532 | $12,971,000 | 0.66% |
| Rhenman & Partners Asset Management AB | 203,181 | $5,577,000 | 0.57% |
| ArrowMark Colorado Holdings LLC | 1,804,275 | $49,527,000 | 0.46% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 87,355 | $2,398,000 | 0.30% |
| FOX RUN MANAGEMENT, L.L.C. | 18,477 | $507,000 | 0.16% |
| Phoenix Investment Adviser LLC | 2,400 | $66,000 | 0.12% |
| Quinn Opportunity Partners LLC | 33,100 | $909,000 | 0.12% |